Genital warts are one of the most common types of sexually transmitted infections. At least half of all sexually active people will become infected with human papillomavirus (HPV), the virus that causes genital warts, at some point during their lives. Women are somewhat more likely than men to develop genital warts.
As the name suggests, genital warts affect the moist tissues of the genital area. Genital warts may look like small, flesh-colored bumps or have a cauliflower-like appearance. In many cases, the warts are too small to be visible.
Like warts that appear elsewhere on your body, genital warts are caused by the human papillomavirus (HPV). Some strains of genital HPV can cause genital warts, while others can cause cancer. Vaccines can help protect against certain strains of genital HPV.
Jan. 02, 2014
- Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, U.K.; New York, N.Y.: Mosby Elsevier; 2010. https://www.clinicalkey.com. Accessed Sept. 5, 2013.
- Genital HPV infection: Fact sheet. Centers for Disease Control and Prevention. http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed Sept. 5, 2013.
- Breen E, et al. Condylomata acuminata (anogenital warts). http://www.uptodate.com/home. Accessed Sept. 5, 2013.
- Goldman L, et al. Goldman's Cecil Medicine. 24th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. https://www.clinicalkey.com. Accessed Sept. 5, 2013.
- Making sense of your Pap and HPV test results. Centers for Disease Control and Prevention. http://www.cdc.gov/std/hpv/pap/default.htm. Accessed Sept. 5, 2013.
- Frequently asked questions: Special procedures — Cervical cancer screening. American Congress of Obstetricians and Gynecologists. http://www.acog.org/~/media/ EC8117ABF5564928A740C4D1B3310E44.ashx. Accessed Sept. 1, 2013.
- Centers for Disease Control and Prevention, et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males — Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports. 2011:60;1705. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm. Accessed Oct. 1, 2013.
- Ali H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: National surveillance data. BMJ. 2013;346:f2032.
- Mikolajczyk RT, et al. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany — an ecologic study. Sexually Transmitted Diseases. 2013;40:28.
- Bauer HM, et al. Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: An analysis of California public family planning administrative claims data, 2007-2010. American Journal of Public Health. 2012;102:833.
- Macartney KK, et al. Safety of human papillomavirus vaccines: A review. Drug Safety. 2013;36:393.
- Rohren CH (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 16, 2013.
- Gallenberg MM (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 24, 2013.